Estimation of the impact of warfarin's time-in-therapeutic range on stroke and major bleeding rates and its influence on the medical cost avoidance associated with novel oral anticoagulant use-learnings from ARISTOTLE, ROCKET-AF, and RE-LY trials - Amin, A; Deitelzweig, S; Jing, Y (J Thromb Thrombolysis, 2014)
et al.